What is the Keppra Patient Assistance Program?
Keppra Patient Assistance Program, a patient assistance program provided by UCB Pharma, offers a six month supply of Keppra at no cost to those who are eligible for the program. Eligibility is based off of the following requirements:
How do I apply to ucbcares UCB Pharma?
- UCBCares UCB PHARMA, INC. Patient must be uninsured or insured medically but with no prescription coverage. Patients with certain Medicare Part D plans may be eligible and can apply to determine eligibility. Online application available on Program Website. Upon approval, quantity will be determined by the prescription accompanying request.
What is the UCB Patient Assistance Program (PAP)?
If you need any financial assistance, you may qualify for the UCB Patient Assistance Program (PAP). You can access the online application here. Choosing the right insurance plan for you and your family can be confusing. We’ve developed a guide to help you navigate the process. At UCB, patients are at the heart of everything we do.
What is UCB Keppra?
Keppra is an anti-epilleptic launched by UCB Pharma in 2006. Keppra has been approved by the FDA to treat partial-onset seizures in adults. Keppra is administered orally via a tablet, or solution.
See more
What is UCB Patient Assistance Program?
Through the UCB Patient Assistance Program, we provide some medications at no cost to eligible and qualified patients who are uninsured or underinsured who otherwise have no access to the UCB medicines prescribed by their physician.
Does Organon have a patient assistance program?
The Organon Co-pay Assistance Program offers assistance to eligible, privately insured patients who need help affording their medication. For product-specific information, please visit your medication website.
How do you qualify for free eliquis?
You may be eligible for the Free 30-Day Trial Offer for ELIQUIS® (apixaban) if:You have not previously filled a prescription for ELIQUIS;You have a valid 30-day prescription for ELIQUIS;You are being treated with ELIQUIS for an FDA-approved indication that an HCP has planned for more than 35 days of treatment;More items...
What is harmony by Organon?
The HARMONY BY ORGANON Patient Support Program provides support services, including coordination with private payers (for patients taking Renflexis, Brenzys or Hadlima) and infusion centres (for patients taking Renflexis).
How to enroll in UCB Pharma?
Fill out the program enrollment form located to your right. If you don't see an enrollment form available please call UCB Pharma program directly. After filling out the enrollment form please bring the form to your doctor for proper signatures and procedures. Do not forget a self stamped envelope for them to mail in your application to the program.
What is UCB Pharma?
UCB Pharma is currently a world leader in antibody research, with over thirty major research and development partners. Their operations span over forty countries, and netted over $3 billion in 2007 alone.
What is Keppra used for?
Keppra is an anti-epilleptic launched by UCB Pharma in 2006. Keppra has been approved by the FDA to treat partial-onset seizures in adults. Keppra is administered orally via a tablet, or solution.
How long is Keppra available?
Keppra Patient Assistance Program, a patient assistance program provided by UCB Pharma, offers a six month supply of Keppra at no cost to those who are eligible for the program. Eligibility is based off of the following requirements:
IMPORTANT NOTE
if you wish to report an adverse event related to one of our products, please contact your healthcare provider. In addition you can contact us using the webform available here
Epilepsy Advocate
Epilepsy Advocates are people living with epilepsy and caregivers seeking the best treatment for controlling their seizures with minimal side effects.
Canine Assistants programme
Canine Assistants was founded in Alpharetta, Georgia, in 1991. This nonprofit organization is dedicated to providing service dogs to children and adults with epilepsy, physical disabilities, and other special needs.
Support of patient organisations in Europe
UCB is committed to comply with Industry self-regulated codes, including the EFPIA Code of Practice on Relationships Between the Pharmaceutical Industry and Patient Organisations.
